{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:16:32Z","timestamp":1783451792214,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA271358"],"award-info":[{"award-number":["P50CA271358"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are limited studies on telehealth use patterns among patients with prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We assessed the patterns of delivery of care for prostate cancer management in the Veterans Health Administration (VHA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A retrospective observational cohort study from January 2016 to February 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Data were from the VHA\u2019s Corporate Data Warehouse (CDW). Veterans with a new diagnosis of prostate cancer were included in the study. Those who died within 1\u00a0year of diagnosis, had missing staging information, or had no prostate-specific antigen (PSA), biopsy, or treatment recorded within 2\u00a0years of initial diagnosis were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measures<\/jats:title>\n                    <jats:p>Veterans were categorized into watchful waiting, active surveillance, and active treatment management groups based on subsequent care received and categorized into National Comprehensive Cancer Network (NCCN) risk categories. We categorized outpatient\u00a0urology or oncology visits as telephone-based, video-based, or in-person using administrative stop codes. We used logistic regression models to evaluate the characteristics associated with at least one video\/virtual visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>In total, 60,381 Veterans were included in the study (20.3% low risk, 49.8% intermediate risk, and 29.8% high risk). Even during the COVID-19 pandemic, less than 6% and 9% of Veterans had at least one urology or oncology video visit, respectively, in the first year after diagnosis across all management groups. In the regression model, Veterans aged 60 and older were less likely to have video visits for both urology and oncology. In contrast, living in urban areas, being diagnosed during the COVID-19 pandemic, and being in the intermediate NCCN risk group were associated with higher odds of having at least one video visit in both specialties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite improvements in telehealth use among Veterans with prostate cancer, telehealth utilization, particularly video visits, remains low, warranting attention from leadership and policymakers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-026-10611-3","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:13:50Z","timestamp":1783448030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Telehealth Utilization for Prostate Cancer Management in the Veteran Affairs Healthcare System: A Study from 2016 to 2023"],"prefix":"10.1007","author":[{"given":"Amin","family":"Nakhostin-Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Dardashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danil","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Orstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah L.","family":"Zullig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1752-7303","authenticated-orcid":false,"given":"Scott E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"10611_CR1","doi-asserted-by":"crossref","unstructured":"Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217\u201322.","DOI":"10.2991\/jegh.k.191008.001"},{"key":"10611_CR2","doi-asserted-by":"crossref","unstructured":"Brawley OW. Prostate cancer epidemiology in the United States. World J Urol. 2012;30:195\u2013200.","DOI":"10.1007\/s00345-012-0824-2"},{"key":"10611_CR3","doi-asserted-by":"crossref","unstructured":"Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben Amor N. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front Cell Dev Biol. 2022;10:991330.","DOI":"10.3389\/fcell.2022.991330"},{"key":"10611_CR4","doi-asserted-by":"crossref","unstructured":"Agochukwu NQ, Skolarus TA, Wittmann D. Telemedicine and prostate cancer survivorship: A narrative review. Mhealth. 2018;4.","DOI":"10.21037\/mhealth.2018.09.08"},{"key":"10611_CR5","doi-asserted-by":"crossref","unstructured":"Nyame YA, Cooperberg MR, Cumberbatch MG, et al. Deconstructing, addressing, and eliminating racial and ethnic inequities in prostate cancer care. Eur Urol. 2022;82(4):341\u201351.","DOI":"10.1016\/j.eururo.2022.03.007"},{"key":"10611_CR6","doi-asserted-by":"crossref","unstructured":"Garfan S, Alamoodi AH, Zaidan B, et al. Telehealth utilization during the Covid-19 pandemic: a systematic review. Computers in biology and medicine. 2021;138:104878.","DOI":"10.1016\/j.compbiomed.2021.104878"},{"key":"10611_CR7","doi-asserted-by":"crossref","unstructured":"Jiang CY, El-Kouri NT, Elliot D, et al. Telehealth for cancer care in veterans: opportunities and challenges revealed by COVID. JCO Oncol Prac. 2021;17(1):22\u20139.","DOI":"10.1200\/OP.20.00520"},{"key":"10611_CR8","doi-asserted-by":"crossref","unstructured":"Leahy M, Krishnasamy M, Herschtal A, et al. Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study. Eur J Oncol Nurs. 2013;17(2):162\u20139.","DOI":"10.1016\/j.ejon.2012.04.003"},{"key":"10611_CR9","doi-asserted-by":"crossref","unstructured":"Loree JM, Dau H, Rebi\u0107 N, et al. Virtual oncology appointments during the initial wave of the COVID-19 pandemic: an international survey of patient perspectives. Curr Oncol. 2021;28(1):671\u20137.","DOI":"10.3390\/curroncol28010065"},{"key":"10611_CR10","doi-asserted-by":"crossref","unstructured":"Viers BR, Lightner DJ, Rivera ME, et al. Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial. Eur Urol. 2015;68(4):729\u201335.","DOI":"10.1016\/j.eururo.2015.04.002"},{"key":"10611_CR11","doi-asserted-by":"crossref","unstructured":"Win AZ. Telehealth can bridge the gap for rural, disabled, and elderly patients. J Am Med Dir Assoc. 2015;16(4):268\u20139.","DOI":"10.1016\/j.jamda.2015.01.077"},{"key":"10611_CR12","doi-asserted-by":"crossref","unstructured":"Garcia JF, Fogel J, Reid M, Bisno DI, Raymond JK. Telehealth for young adults with diabetes: addressing social determinants of health. Diabetes Spectrum: A Publication of the American Diabetes Association. 2021;34(4):357.","DOI":"10.2337\/dsi21-0011"},{"key":"10611_CR13","doi-asserted-by":"crossref","unstructured":"Latifi R, Doarn CR. Perspective on COVID-19: finally, telemedicine at center stage. Telemed J E Health. 2020;26(9):1106\u20139.","DOI":"10.1089\/tmj.2020.0132"},{"key":"10611_CR14","doi-asserted-by":"crossref","unstructured":"Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. N Engl J Med. 2020;382(18):1679\u201381.","DOI":"10.1056\/NEJMp2003539"},{"key":"10611_CR15","doi-asserted-by":"crossref","unstructured":"Chen J, Oromendia C, Halpern JA, Ballman KV. National trends in management of localized prostate cancer: A population based analysis 2004\u20102013. The Prostate. 2018;78(7):512\u201320.","DOI":"10.1002\/pros.23496"},{"key":"10611_CR16","doi-asserted-by":"crossref","unstructured":"Hoffman RM, Mott SL, McDowell BD, Anand ST, Nepple KG. Trends and practices for managing low-risk prostate cancer: a SEER-Medicare study. Prostate cancer and prostatic diseases. 2022;25(1):100\u20138.","DOI":"10.1038\/s41391-021-00393-6"},{"key":"10611_CR17","doi-asserted-by":"crossref","unstructured":"Loeb S, Byrne N, Makarov DV, Lepor H, Walter D. Use of conservative management for low-risk prostate cancer in the Veterans Affairs Integrated Health Care System from 2005-2015. Jama. 2018;319(21):2231\u20133.","DOI":"10.1001\/jama.2018.5616"},{"key":"10611_CR18","doi-asserted-by":"crossref","unstructured":"Chen LW, Usinger DS, Katz AJ. Telehealth use and perceptions among prostate cancer survivors. Cancer Med. 2023;12(16):17308\u201312.","DOI":"10.1002\/cam4.6328"},{"key":"10611_CR19","doi-asserted-by":"crossref","unstructured":"Chimonas S, Lipitz-Snyderman A, Spiegelhoff Z, et al. Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic. Cancers. 2023;15(20):4961.","DOI":"10.3390\/cancers15204961"},{"key":"10611_CR20","unstructured":"U.S Department of Veterans Affairs. About VHA. Available from: https:\/\/www.va.gov\/health\/aboutvha.asp."},{"key":"10611_CR21","doi-asserted-by":"crossref","unstructured":"Zullig LL, Makarov D, Becker D, et al. Telehealth research and innovation for veterans with cancer: the THRIVE center. JNCI Monographs. 2024;2024(64):70\u20135.","DOI":"10.1093\/jncimonographs\/lgae019"},{"key":"10611_CR22","doi-asserted-by":"crossref","unstructured":"Yamoah K, Lee KM, Awasthi S, et al. Racial and ethnic disparities in prostate cancer outcomes in the veterans affairs health care system. JAMA Network Open. 2022;5(1):e2144027-e.","DOI":"10.1001\/jamanetworkopen.2021.44027"},{"key":"10611_CR23","doi-asserted-by":"crossref","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.","DOI":"10.1371\/journal.pmed.1001885"},{"key":"10611_CR24","unstructured":".Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio medica: Atenei parmensis. 2020;91(1):157."},{"key":"10611_CR25","doi-asserted-by":"crossref","unstructured":"Alba PR, Gao A, Lee KM, et al. Ascertainment of veterans with metastatic prostate cancer in electronic health records: demonstrating the case for natural language processing. JCO Clin Cancer Inform. 2021;5:1005\u201314.","DOI":"10.1200\/CCI.21.00030"},{"key":"10611_CR26","doi-asserted-by":"crossref","unstructured":"Ferguson JM, Jacobs J, Yefimova M, Greene L, Heyworth L, Zulman DM. Virtual care expansion in the Veterans Health Administration during the COVID-19 pandemic: clinical services and patient characteristics associated with utilization. J Am Med Inform Assoc. 2021;28(3):453\u201362.","DOI":"10.1093\/jamia\/ocaa284"},{"key":"10611_CR27","doi-asserted-by":"crossref","unstructured":"Davies BJ, Walsh TJ, Ross PL, et al. Effect of BMI on primary treatment of prostate cancer. Urology. 2008;72(2):406\u201311.","DOI":"10.1016\/j.urology.2007.11.032"},{"key":"10611_CR28","doi-asserted-by":"crossref","unstructured":"Foerster B, Pozo C, Abufaraj M, et al. Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and meta-analysis. JAMA Oncol. 2018;4(7):953-61.","DOI":"10.1001\/jamaoncol.2018.1071"},{"key":"10611_CR29","doi-asserted-by":"crossref","unstructured":"Reese AC, Pierorazio PM, Han M, Partin AW. Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system. Urology. 2012;80(5):1075\u20139.","DOI":"10.1016\/j.urology.2012.07.040"},{"key":"10611_CR30","doi-asserted-by":"crossref","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B: Statistical Methodology. 1996;58(1):267\u201388.","DOI":"10.1111\/j.2517-6161.1996.tb02080.x"},{"key":"10611_CR31","doi-asserted-by":"crossref","unstructured":"Ko JS, El\u2010Toukhy S, Quintero SM, et al. Disparities in telehealth access, not willingness to use services, likely explain rural telehealth disparities. J Rural Health. 2023;39(3):617\u201324.","DOI":"10.1111\/jrh.12759"},{"key":"10611_CR32","doi-asserted-by":"crossref","unstructured":"Javier-DesLoges J, Meagher M, Soliman S, et al. Disparities in telemedicine utilization for urology patients during the COVID-19 pandemic. Urology. 2022;163:76\u201380.","DOI":"10.1016\/j.urology.2021.11.037"},{"key":"10611_CR33","doi-asserted-by":"crossref","unstructured":"Friedman JH, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","DOI":"10.18637\/jss.v033.i01"},{"key":"10611_CR34","doi-asserted-by":"crossref","unstructured":"Fox J, Weisberg S. An R companion to applied regression: Sage publications; 2018.","DOI":"10.32614\/CRAN.package.carData"},{"key":"10611_CR35","doi-asserted-by":"crossref","unstructured":"Kumar D, Gordon N, Zamani C, et al. Cancer patients\u2019 preferences and perceptions of advantages and disadvantages of telehealth visits during the COVID-19 pandemic. JCO Clin Cancer Inform. 2023;7:e2300040.","DOI":"10.1200\/CCI.23.00040"},{"key":"10611_CR36","doi-asserted-by":"crossref","unstructured":"Barsom EZ, Jansen M, Tanis PJ, et al. Video consultation during follow up care: effect on quality of care and patient-and provider attitude in patients with colorectal cancer. Surg Endosc. 2021;35:1278\u201387.","DOI":"10.1007\/s00464-020-07499-3"},{"key":"10611_CR37","doi-asserted-by":"crossref","unstructured":"Albritton J, Ortiz A, Wines R, et al. Video teleconferencing for disease prevention, diagnosis, and treatment: a rapid review. Ann Intern Med. 2022;175(2):256\u201366.","DOI":"10.7326\/M21-3511"},{"key":"10611_CR38","doi-asserted-by":"crossref","unstructured":"Chang PJ, Jay GM, Kalpakjian C, Andrews C, Smith S. Patient and provider\u2010reported satisfaction of cancer rehabilitation telemedicine visits during the COVID\u201019 pandemic. PM&R. 2021;13(12):1362\u20138.","DOI":"10.1002\/pmrj.12552"},{"key":"10611_CR39","doi-asserted-by":"crossref","unstructured":"Dang S, Muralidhar K, Li S, et al. Gap in willingness and access to video visit use among older high-risk veterans: cross-sectional study. J Med Internet Res. 2022;24(4):e32570.","DOI":"10.2196\/32570"},{"key":"10611_CR40","doi-asserted-by":"crossref","unstructured":"Dhanani Z, Ferguson JM, Van Campen J, et al. Overcoming access barriers for veterans: Cohort study of the distribution and use of veterans affairs\u2019 video-enabled tablets before and during the COVID-19 pandemic. J Med Internet Res. 2023;25:e42563.","DOI":"10.2196\/42563"},{"key":"10611_CR41","doi-asserted-by":"crossref","unstructured":"Naik N, Hameed BZ, Nayak SG, et al. Telemedicine and Telehealth in Urology\u2014What Do the \u2018Patients\u2019 Think About It? Frontiers in Surgery. 2022;9:863576.","DOI":"10.3389\/fsurg.2022.863576"},{"key":"10611_CR42","doi-asserted-by":"crossref","unstructured":"Jerjes W, Harding D. Telemedicine in the post-COVID era: balancing accessibility, equity, and sustainability in primary healthcare. Front Digit Health. 2024;6:1432871.","DOI":"10.3389\/fdgth.2024.1432871"},{"key":"10611_CR43","doi-asserted-by":"crossref","unstructured":"43.Fu J, Fu C, Wang RS, et al. Current status and future direction to address disparities in diversity, equity, and inclusion in prostate cancer care. Curr Oncol Rep. 2023;25(7):699\u2013708.","DOI":"10.1007\/s11912-023-01399-0"},{"key":"10611_CR44","doi-asserted-by":"crossref","unstructured":"Miller M, Ekaireb R, Woods A, Wick E, Sarin A. Telehealth Policy and Rural-Urban Disparities in Cancer Care Access. Ann Surg. 2026;283(1):40\u20132.","DOI":"10.1097\/SLA.0000000000006788"},{"key":"10611_CR45","doi-asserted-by":"crossref","unstructured":"Snoswell CL, Taylor ML, Comans TA, Smith AC, Gray LC, Caffery LJ. Determining if telehealth can reduce health system costs: scoping review. J Med Internet Res. 2020;22(10):e17298.","DOI":"10.2196\/17298"},{"key":"10611_CR46","doi-asserted-by":"crossref","unstructured":"Wong V, Cohen J, Ingram A, et al. Patient-centered cost saving and positive environmental impact with the introduction of telehealth services at a single center. Urol Pract. 2025;12(1):44\u201350.","DOI":"10.1097\/UPJ.0000000000000723"},{"key":"10611_CR47","doi-asserted-by":"crossref","unstructured":"Der-Martirosian C, Wyte-Lake T, Balut M, et al. Implementation of telehealth services at the US Department of Veterans Affairs during the COVID-19 pandemic: mixed methods study. JMIR Form Res. 2021;5(9):e29429.","DOI":"10.2196\/29429"},{"key":"10611_CR48","doi-asserted-by":"crossref","unstructured":"Wilson FA, Rampa S, Trout KE, Stimpson JP. Reimbursements for telehealth services are likely to be lower than non-telehealth services in the United States. J Telemed Telecare. 2017;23(4):497\u2013500.","DOI":"10.1177\/1357633X16652288"},{"key":"10611_CR49","doi-asserted-by":"crossref","unstructured":"Singh J, Albertson A, Sillerud B, editors. Telemedicine during COVID-19 crisis and in post-pandemic\/post-vaccine world\u2014historical overview, current utilization, and innovative practices to increase utilization. Healthcare; 2022: MDPI.","DOI":"10.3390\/healthcare10061041"},{"key":"10611_CR50","doi-asserted-by":"crossref","unstructured":"Predmore Z, Roth E, Breslau J, Fischer S, Uscher-Pines L. Assessment of patient preferences for telehealth in post-COVID-19 pandemic health care. JAMA Netw Open. 2021; 4 (12): e2136405. 2021.","DOI":"10.1001\/jamanetworkopen.2021.36405"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10611-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:15:05Z","timestamp":1783448105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10611-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":50,"alternative-id":["10611"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10611-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) at the Veterans Affairs (VA) New York Harbor Healthcare System.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"Leah L. Zullig currently serves as a consultant for Eisai Pharmaceutical Company; however, this relationship is unrelated to this work. The other authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}